About MedAvante-ProPhase
MedAvante-ProPhase is a company based in Hamilton (United States) founded in 2002 by Paul Gilbert was acquired by WIRB-Copernicus Group in May 2017. MedAvante-ProPhase has raised $2.29 million across 1 funding round from investors including WIRB-Copernicus Group and Arsenal Capital Partners. MedAvante-ProPhase offers products and services including IRB Review, Site Enablement, and Clinical Endpoints. MedAvante-ProPhase operates in a competitive market with competitors including Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic, among others.
- Headquarter Hamilton, United States
- Founders Paul Gilbert
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.29 M (USD)
in 1 rounds
-
Latest Funding Round
$2.29 M (USD), Series A
Oct 08, 2015
-
Investors
WIRB-Copernicus Group
& 1 more
-
Employee Count
Not available
-
Acquired by
WIRB-Copernicus Group
(May 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedAvante-ProPhase
MedAvante-ProPhase offers a comprehensive portfolio of products and services, including IRB Review, Site Enablement, and Clinical Endpoints.
Service for ethical and scientific review of clinical trials
Platform for site preparation and operational support
Tools for monitoring and assessing trial outcomes
People of MedAvante-ProPhase
Unlock access to complete
Unlock access to complete
Software Development Team
65 people
Operations Team
56 people
Leadership Team
46 people
Senior Team
36 people
Sales and Marketing
28 people
Project Team
19 people
Legal and Compliance
14 people
Finance and Accounting
14 people
Unlock access to complete
Funding Insights of MedAvante-ProPhase
MedAvante-ProPhase has successfully raised a total of $2.29M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.29 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MedAvante-ProPhase
MedAvante-ProPhase has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include WIRB-Copernicus Group and Arsenal Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments target specialty industrials and healthcare sectors.
|
Locked | Locked | Locked | |
|
Regulatory and ethical review services for clinical research are provided.
|
Locked | Locked | Locked |
Investor details for MedAvante-ProPhase
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedAvante-ProPhase
Investment portfolio details for MedAvante-ProPhase
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedAvante-ProPhase
Detailed financials for MedAvante-ProPhase
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medavante-Prophase Comparisons
Peer comparison for MedAvante-ProPhase
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedAvante-ProPhase
MedAvante-ProPhase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical trial management solutions are provided through Suvoda's IRT system.
|
|
| Locked | Locked | Locked |
Research site network platform focuses on patient identification, enrollment, recruitment & retention
|
|
| Locked | Locked | Locked |
HumanFirst is integrated into ICON, focusing on digital health solutions.
|
|
| Locked | Locked | Locked |
Contract research organization that offers a complete suite of CRO services for decentralized clinical trials
|
|
| Locked | Locked | Locked |
Solutions for medical image analysis, data management, workflow automation & EPR collection
|
Detailed competitors of MedAvante-ProPhase
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medavante-Prophase
Complete news archive for MedAvante-ProPhase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedAvante-ProPhase
MedAvante-ProPhase was founded in 2002 and raised its 1st funding round 13 years after it was founded.
MedAvante-ProPhase is headquartered in Hamilton, United States.
MedAvante-ProPhase is a funded company, having raised a total of $2.29M across 1 funding round to date.
MedAvante-ProPhase was founded in 2002 and is based in Hamilton, United States. Operations focus on the healthcare technology sector, where eSource data capture and electronic data management systems are offered for clinical trials. The flagship Virgil Investigative Study Platform is utilized for signal detection, incorporating tablet-based interfaces with context-sensitive rating scales and clinical guidance tailored to specific studies. Services support data integrity and efficiency in trial processes.
MedAvante-ProPhase's top competitors include Suvoda, HumanFirst and Circuit Clinical.
MedAvante-ProPhase offers IRB Review, Site Enablement, and Clinical Endpoints.
MedAvante-ProPhase has 2 investors. Key investors include WIRB-Copernicus Group, and Arsenal Capital Partners.